Law Office of Brodsky & Smith, LLC Announces Investigation of Synovis Life Technologies, Inc.
14 Dezembro 2011 - 8:24PM
Business Wire
Law office of Brodsky & Smith, LLC announces that it is
investigating potential claims against the Board of Directors of
Synovis Life Technologies, Inc. (“Synovis” or the “Company”)
(Nasdaq: SYNO) relating to the proposed acquisition by Baxter
International, Inc. (“Baxter”) (NYSE: BAX).
Under the terms of the transaction, Synovis shareholders would
receive $28.00 in cash for each share of Synovis common stock they
own. The transaction has a total approximate value of $325 million.
The investigation concerns possible breaches of fiduciary duty and
other violations of state law by the Board of Directors of Synovis
for not acting in Synovis shareholders' best interests in
connection with the sale process to Baxter.
If you own shares of Synovis and wish to discuss the legal
ramifications of the proposed transaction, or have any questions,
you may e-mail or call the law office of Brodsky & Smith, LLC
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Jason L. Brodsky, Esquire or Evan J.
Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, visiting
http://brodsky-smith.com/369-syno-synovis-life-technologies-inc.html,
or by calling toll free 877-LEGAL-90.
Synovis Life Technologies, Inc. (MM) (NASDAQ:SYNO)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Synovis Life Technologies, Inc. (MM) (NASDAQ:SYNO)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Synovis Life Technologies, Inc. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Brodsky & Smith, LLC